Correlations of health-related quality of life with serum inflammatory indicators IL-8 and mIBI in patients with hepatocellular carcinoma

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• KimUBDooCJBaekSHNatural history and prognostic factors of primary hepatocellular carcinoma: study of 70 untreated patientsKorean J Intern Med1989421361422562101
   PubMedGoogle Scholar
• CalvetXBruixJGinésPPrognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patientsHepatology1990124 Pt 17537602170267
   PubMed Web of Science ®Google Scholar
• PawarodeAVoravudNSriuranpongVKullavanijayaPPattYZNatural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patientsAm J Clin Oncol19982143863919708639
   PubMed Web of Science ®Google Scholar
• OkudaKOhtsukiTObataHNatural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patientsCancer19855649189282990661
   PubMed Web of Science ®Google Scholar
• YeoWMoFKKohJQuality of life is predictive of survival in patients with unresectable hepatocellular carcinomaAnn Oncol20061771083108916600982
   PubMed Web of Science ®Google Scholar
• BonnetainFPaolettiXColletteSQuality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trialsQual Life Res200817683184318618292
   PubMed Web of Science ®Google Scholar
• DioufMFilleronTBarbareJCThe added value of quality of life (QOL) for prognosis of overall survival in patients with palliative hepatocellular carcinomaJ Hepatol201358350952123178978
   PubMed Web of Science ®Google Scholar
• LiLMoFKChanSLPrognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life dataBMC Cancer2017171828052758
   PubMedGoogle Scholar
• LiLYeoWValue of quality of life analysis in liver cancer: a clinician’s perspectiveWorld J Hepatol201792086788328804570
   PubMedGoogle Scholar
• GretenTFDuffyAGKorangyFHepatocellular carcinoma from an immunologic perspectiveClin Cancer Res201319246678668524030702
   PubMed Web of Science ®Google Scholar
• WanSKuoNKryczekIZouWWellingTHMyeloid cells in hepatocellular carcinomaHepatology20156241304131225914264
   PubMed Web of Science ®Google Scholar
• HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
   PubMed Web of Science ®Google Scholar
• Hernandez-GeaVToffaninSFriedmanSLLlovetJMRole of the microenvironment in the pathogenesis and treatment of hepatocellular carcinomaGastroenterology2013144351252723313965
   PubMed Web of Science ®Google Scholar
• AriharaFMizukoshiEKitaharaMIncrease in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosisCancer Immunol Immunother20136281421143023764929
   PubMed Web of Science ®Google Scholar
• ChewVTowCTeoMInflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patientsJ Hepatol201052337037919720422
   PubMed Web of Science ®Google Scholar
• JangJWOhBSKwonJHSerum IL-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinomaCytokine201260368669322906998
   PubMed Web of Science ®Google Scholar
• ChoHJKimSSAhnSJLow serum IL-6 levels as a predictive marker of recurrence in patients with hepatitis B virus related hepatocellular carcinoma who underwent curative treatmentCytokine201573224525225797190
   PubMed Web of Science ®Google Scholar
• QiuXWangXSongYChenLPlasma level of IL-35 as an independent prognostic indicator in hepatocellular carcinomaDig Dis Sci201661123513352127699510
   PubMed Web of Science ®Google Scholar
• ChenZYWeiWGuoZXUsing multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohortsBr J Cancer2014110373374024495874
   PubMed Web of Science ®Google Scholar
• WellingTHFuSWanSZouWMarreroJAElevated serum IL-8 is associated with the presence of hepatocellular carcinoma and independently predicts survivalCancer Invest2012301068969723072563
   PubMed Web of Science ®Google Scholar
• KimSSChoHJWonJHIL-8 level as a prognostic marker in patients with hepatitis B virus-associated hepatocellular carcinoma treated with transarterial chemoembolizationCytokine201576244945726163999
   PubMed Web of Science ®Google Scholar
• ChanSLChanAWChanAKSystematic evaluation of circulating inflammatory markers for hepatocellular carcinomaLiver Int201737228028927501075
   PubMed Web of Science ®Google Scholar
• Sternby EilardMHagströmHMortensenKEQuality of life as a prognostic factor for survival in hepatocellular carcinomaLiver Int201838588589428941130
   PubMed Web of Science ®Google Scholar
• Oliveira MirandaDSoares de LimaTARibeiro AzevedoLFeresORibeiro da RochaJJPereira-da-SilvaGProinflammatory cytokines correlate with depression and anxiety in colorectal cancer patientsBiomed Res Int20142014515
   Google Scholar
• KaoSCVardyJHarvieRHealth-related quality of life and inflammatory markers in malignant pleural mesotheliomaSupport Care Cancer201321369770522936495
   PubMed Web of Science ®Google Scholar
• Lynch KellyDLyonDEAmeringerSAElswickRKSymptoms, cytokines, and quality of life in patients diagnosed with chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantationOncol Nurs Forum201542326527525901378
   PubMed Web of Science ®Google Scholar
• PanjuAHDaneshAMindenMDKelvinDJAlibhaiSMAssociations between quality of life, fatigue, and cytokine levels in patients aged 50+ with acute myeloid leukemiaSupport Care Cancer200917553954618931862
   PubMed Web of Science ®Google Scholar
• PaulsenØLairdBAassNThe relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancerPLoS One2017125e017762028542626
   PubMed Web of Science ®Google Scholar
• ChibaFSodaKYamadaSThe importance of tissue environment surrounding the tumor on the development of cancer cachexiaInt J Oncol201444117718624247481
   PubMed Web of Science ®Google Scholar
• AaronsonNKAhmedzaiSBergmanBThe European Organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ Natl Cancer Inst19938553653768433390
   PubMed Web of Science ®Google Scholar
• BlazebyJMCurrieEZeeBCDevelopment of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18Eur J Cancer200440162439244415519517
   PubMed Web of Science ®Google Scholar
• OhBButowPMullanBImpact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trialAnn Oncol201021360861419880433
   PubMed Web of Science ®Google Scholar
• SprodLKJanelsinsMCPaleshOGHealth-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuanJ Cancer Surviv20126214615422160628
   PubMed Web of Science ®Google Scholar
• HojanKKwiatkowska-BorowczykELeporowskaEMileckiPInflammation, cardiometabolic markers, and functional changes in men with prostate cancer. A randomized controlled trial of a 12-month exercise programPol Arch Intern Med20171271253528075422
   PubMedGoogle Scholar
• PanahiYSaadatABeiraghdarFSahebkarAAdjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trialPhytother Res201428101461146724648302
   PubMed Web of Science ®Google Scholar